Overview

The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar

Status:
Unknown status

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

To evaluate the change of blood perfusion before/after the use of Endostar, discuss the time sequence of Endostar TM in treating advanced lung adenocarcinoma in normalization window period.

Phase:

Phase 2

Details

Lead Sponsor:

Simcere Pharmaceutical Co., Ltd

Treatments:

Endostar protein